Goldman Sachs Reiterates Neutral Rating on Incyte (INCY)
Tweet Send to a Friend
Goldman Sachs analyst Salveen Richter reiterated a Neutral rating and $60.00 price target on Incyte (NASDAQ: INCY).The analyst comments "INCY ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


